Mouse Anti-CCNO Recombinant Antibody (CBXC-1782) (CBMAB-C4673-CQ)

This product is a mouse antibody that recognizes CCNO. The antibody CBXC-1782 can be used for immunoassay techniques such as: WB, IP, IF, ELISA.
See all CCNO antibodies

Datasheet

Summary

Host Animal

Mouse

Specificity

Human

Clone

CBXC-1782

Antibody Isotype

IgG

Application

WB, IP, IF, ELISA

Basic Information

Specificity

Human

Antibody Isotype

IgG

Clonality

Monoclonal

Application Notes

The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Storage

Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

Full Name

Cyclin O

Introduction

CCNO (Cyclin O) is a Protein Coding gene. Diseases associated with CCNO include Ciliary Dyskinesia, Primary, 29 and Primary Ciliary Dyskinesia. Gene Ontology (GO) annotations related to this gene include protein kinase binding and uracil DNA N-glycosylase activity. An important paralog of this gene is CCNB1.

Entrez Gene ID

10309

UniProt ID

P22674

Alternative Names

Cyclin O; Cyclin U; Cyclin Domain Containing; Cyclin-O; CILD29; UDG2; CCNU;

Function

Specifically required for generation of multiciliated cells, possibly by promoting a cell cycle state compatible with centriole amplification and maturation. Acts downstream of MCIDAS to promote mother centriole amplification and maturation in preparation for apical docking.

Biological Process

Cell division Source: UniProtKB-KW
Cilium assembly Source: UniProtKB
Mitotic cell cycle Source: UniProtKB
Mitotic cell cycle phase transition Source: GO_Central
Multi-ciliated epithelial cell differentiation Source: UniProtKB
Regulation of cyclin-dependent protein serine/threonine kinase activity Source: GO_Central
Response to drug Source: Ensembl

Cellular Location

Cytoplasm; Nucleolus. Localizes to the apical part of cytoplasm.

Involvement in disease

Ciliary dyskinesia, primary, 29 (CILD29): The disease is caused by variants affecting the gene represented in this entry. Marked reduction of cilia in multiciliate cells due to defective mother centriole generation and placement. Remaining cilia correctly express axonemal motor proteins, are motile and do not show beating defects. Defects are probably caused by a strong reduction in the number of multiple motile cilia covering the cell surface in respiratory epithelial cells (PubMed:24747639). A disorder characterized by abnormalities of motile cilia. Respiratory infections leading to chronic inflammation and bronchiectasis are recurrent, due to defects in the respiratory cilia. CILD29 patients do not exhibit situs inversus, a congenital abnormality in which visceral organs are opposite to their normal positions (situs solitus) due to lateral transposition.

References

Xu, X., Dong, L., Ma, C., Xu, X., Wu, H., Wang, J., ... & Wei, Z. (2021). Establishment of an induced pluripotent stem cell line from a patient with primary ciliary dyskinesia carrying biallelic mutations in CCNO. Stem Cell Research, 53, 102372.

Ma, C., Wu, H., Zhu, D., Wang, Y., Shen, Q., Cheng, H., ... & Xu, X. (2021). Bi‐allelic mutations in MCIDA S and CCNO cause human infertility associated with abnormal gamete transport. Clinical Genetics, 100(6), 731-742.

Wang, J., & Chen, S. (2020). RACK1 promotes miR-302b/c/d-3p expression and inhibits CCNO expression to induce cell apoptosis in cervical squamous cell carcinoma. Cancer Cell International, 20(1), 1-12.

Dahlmann, J., Sahabian, A., Drick, N., Haase, A., Göhring, G., Lachmann, N., ... & Olmer, R. (2020). Generation of two hiPSC lines (MHHi016-A, MHHi016-B) from a primary ciliary dyskinesia patient carrying a homozygous 5 bp duplication (c. 248_252dup (p. Gly85Cysfs* 11)) in exon 1 of the CCNO gene. Stem Cell Research, 46, 101850.

Li, L., Cao, Y., Zhou, H., Li, Y., He, B., Zhou, X., ... & Ye, L. (2018). Knockdown of CCNO decreases the tumorigenicity of gastric cancer by inducing apoptosis. OncoTargets and therapy, 11, 7471.

Núnez-Ollé, M., Jung, C., Terré, B., Balsiger, N. A., Plata, C., Roset, R., ... & Gil-Gómez, G. (2017). Constitutive Cyclin O deficiency results in penetrant hydrocephalus, impaired growth and infertility. Oncotarget, 8(59), 99261.

Q & As

Ask a question We look forward to hearing from you.

0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Review & reward

Have you used Mouse Anti-CCNO Recombinant Antibody (CBXC-1782)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon

$30 eGift Card
Submit a review

Protocols

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols

Associated Products

Isotype control

For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Documents

Datasheet
SDS
Request for COA

Request bulk or custom quote

Second antibody and isotype control

Contact us

Tel: (USA)
(UK)
Fax:

Global Locations

Email: